2024-10-20 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis Report

**1. Performance Overview**

Thermo Fisher Scientific Inc. (TMO) is a leading provider of scientific instruments, consumables, and services for research, analysis, and diagnostics. 

**Cumulative Return:** 243.81%
**S&P 500 (VOO) Cumulative Return:** 137.88%
**Performance Difference:** 105.93%
**Relative Performance:** 49.03% (This means TMO's performance is currently at the 49th percentile of its historical range compared to the S&P 500). 

**2. Recent Price Movement**

**Closing Price:** 601.71
**5-day Moving Average:** 599.36
**20-day Moving Average:** 604.06
**60-day Moving Average:** 607.44

The stock price is currently trading slightly below its 20-day and 60-day moving averages, suggesting potential short-term weakness.

**3. Technical Indicators**

**RSI:** 37.74 (Below 50, suggesting potential oversold conditions)
**PPO:** -0.09 (Negative, indicating downward momentum)
**Delta_Previous_Relative_Divergence:** -5.95 (Negative, indicating short-term downward trend)
**Expected Return:** 36.77% (This represents the potential long-term (2+ years) outperformance compared to the S&P 500 based on historical data)

**4. Recent Earnings and Outlook**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-02 | 4.05 | $10.54B |
| 2024-05-03 | 3.47 | $10.35B |
| 2023-11-03 | 4.44 | $10.57B |
| 2023-08-04 | 3.53 | $10.69B |
| 2024-08-02 | 3.53 | $10.69B |

The most recent earnings report for Q2 2024 showed EPS of $4.05, exceeding analyst estimates of $3.91. Revenue of $10.54B was also above estimates. The company has consistently exceeded revenue and earnings expectations, demonstrating strong growth. 

**5. News and Recent Issues**

**Recent Market Outlook for TMO:** The market sentiment surrounding Thermo Fisher Scientific Inc. (TMO) is largely positive, with analysts citing its strong growth prospects and consistent performance. 

**Analyst Opinions and Performance Highlights:**
* **FINBOLD:** Analysts at FINBOLD are bullish on TMO, with a median price target of $700. They highlight the company's strong position in the life sciences and diagnostics markets, as well as its impressive track record of innovation. 
* **Barron's:** A recent Barron's article highlighted TMO's dominance in the laboratory equipment market and its expansion into the biopharmaceutical and diagnostics sectors. They suggest that TMO is well-positioned for continued growth, driven by global demand for scientific research and healthcare solutions.

**6. Overall Analysis**

Thermo Fisher Scientific Inc. (TMO) has a history of outperforming the S&P 500, exhibiting strong financial performance and positive market sentiment. While the recent price movement indicates potential short-term weakness, the company's fundamentals remain strong, with strong growth prospects and a robust position in the scientific research and healthcare markets. 

**7. Key Takeaways**

* TMO has consistently outperformed the S&P 500, with a strong track record of earnings and revenue growth.
* Recent price movement suggests potential short-term weakness, but the company's fundamentals remain strong.
* Analysts are bullish on TMO's future prospects, citing its dominance in the lab equipment market and expansion into biopharmaceuticals and diagnostics.
* The stock's RSI and PPO indicators suggest potential oversold conditions, making it a potential entry point for long-term investors.
* The expected return of 36.77% is attractive for investors looking for long-term growth.

**Disclaimer:** This analysis is for informational purposes only and should not be considered investment advice. It is essential to conduct thorough research and consult with a financial advisor before making any investment decisions. 
